![]() Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. | ![]() Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | ![]() OncoDNA OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients. | |
Founding Date | Founding Date 1998 | Founding Date 1999 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Boston, US HQ Jerusalem, IL | Locations Marseille, FR HQ Rockville, US | Locations Charleroi, BE HQ |
Employees | Employees 143175% increase | Employees 181 | Employees 502% increase |
Valuation ($) | Valuation ($) 4.3 m | Valuation ($) 148.6 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) €2.8m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.5m (FY, 2023) | Cost of goods €266k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $330k (FY, 2023) | Gross profit €8.7m (FY, 2025) | Gross profit N/A |
Net income | Net income ($63m) (FY, 2023) | Net income (€49.2m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 128.3m | Total funding raised $ 94.1m | Total funding raised $ 29.8m |

Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
View company